FDA Grants and Tax Credits for Rare Disease Research
FDA Grants and Tax Credits for Rare Disease Research How FDA Grants and Tax Credits Empower Rare Disease Research Why Financial Incentives Are Vital in Rare Disease Development Developing therapies for rare diseases often involves small patient populations, high R&D costs, and uncertain return on investment. To address these challenges, the U.S. government—particularly through the…
Read More “FDA Grants and Tax Credits for Rare Disease Research” »